Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells

Journal of Cellular Biochemistry

Volumn 101, Issue 6, 2007, Pages 1505-1519

  Valrance, Meggan E ^a   Brunet, Andrea H ^b   Acosta, Anna ^a   Welsh, JoEllen ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

1 ,25 dihydroxyvitamin D 3; Apoptosis; Breast cancer; Mammary tumor cells; Vitamin d receptor

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALPAIN; CASPASE; CYTOCHROME P450 24; CYTOCHROME P450 27B1; CYTOCHROME P450 ISOENZYME; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; GROWTH REGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIFEDIOL; CELL LINE; CELL NUCLEUS; ENZYME INDUCTION; FEMALE; GENES, REPORTER; LIGANDS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; TRANSCRIPTION, GENETIC; VITAMIN D;

MURINAE; MUS;

EID: 34547737407     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21263     Document Type: Article

References (48)

1. Berry DM, Antochi R, Bhatia M, Meckling-Gill KA. 1996. 1, 25-Dihydroxyvitamin D3 stimulates expression and translocation of protein kinase Calpha and Cdelta via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells. J Biol Chem 271:16090-16096.
2. Bettoun DJ, Buck DW 2nd, Lu J, Khalifa B, Chin WW, Nagpal S. 2002. A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J Biol Chem 277:24847-24850.
3. Bettoun DJ, Lu J, Khalifa B, Yee Y, Chin WW, Nagpal S. 2004. Ligand modulates VDR-Ser/Thr protein phosphatase interaction and p70S6 kinase phosphorylation in a cell-context-dependent manner. J Steroid Biochem Mol Biol 89-90:195-198.
4. Bhatia M, Kirkland JB, Meckling-Gill KA. 1995. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1, 25-dihydroxyvitamin D3 is independent of nuclear receptor binding. J Biol Chem 270:15962-15965.
5. Bula CM, Huhtakangas J, Olivera C, Bishop JE, Norman AW, Henry HL. 2005. Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 146:5581-5586.
6. Capiati DA, Rossi AM, Picotto G, Benassati S, Boland RL. 2004. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha, 25(OH)2-vitamin D3 in MCF-7 breast cancer cells. J Cell Biochem 93:384-397.
7. Cheng HT, Chen JY, Huang YC, Chang HC, Hung WC. 2006. Functional role of VDR in the activation of p27Kip1 by the VDR/Sp1 complex. J Cell Physiol 98:1450-1456.
8. Colston KW, Welsh J. 2005. Vitamin D and Breast Cancer. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D. 2nd Edition. San Diego, CA: Elsevier/Academic Press, pp 1663-1677.
9. Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C. 1997. Sensitive induction of apoptosis in breast cancer cells by a novel 1, 25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem 66:552-562.
10. Friedrich M, Reichrath J, Chen T, et al. 2000. Expression of 25-hydroxyvitamin D3 1-hydroxylase in breast tissue. In: Norman A, Bouillon R, Thomasset M, editors. Vitamin D endocrine system: Structural, biological, genetic and clinical aspects. Riverside, CA: University of Riverside Press, pp 189-191.
11. Gombart AF, Luong QT, Koeffler HP. 2006. Vitamin D compounds: Activity against microbes and cancer. Anticancer Res 26:2531-2542.
12. Guzey M, Kitada S, Reed J. 2002. Apoptosis induction by 1alpha, 25-dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther 1:667-677.
13. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
14. 3. Oncogene 23:4856-4861.
15. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW. 2004. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18:2660-2671.
16. Jurutka PW, Thompson PD, Whitfield GK, Eichhorst KR, Hall N, Dominguez CE, Hsieh JC, Haussler CA, Haussler MR. 2005. Molecular and functional comparison of 1, 25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3 A4. J Cell Biochem 94:917-943.
17. Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S, Cross HS. 2001. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429-1435.
18. Kemmis CM, Salvador SM, Smith KM, Welsh J. 2006. Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3. J Nutr 136:887-892.
19. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 94:9831-9835.
20. Lowe L, Hansen CM, Senaratne S, Colston KW. 2003. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res 164:99-110.
21. Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS. 2006. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1, 25D3-mediated apoptosis in squamous cell carcinoma cells. Cancer Res 66:8131-8138.
22. Malloy PJ, Feldman D. 2003. Hereditary 1, 25-Dihydroxyvitamin D-resistant rickets. Endocr Dev 6:175-199.
23. Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW, Jaattela M. 2002. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 277:30738-30745.
24. McCarthy TC, Li X, Sinal CJ. 2005. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280:23232-23242.
25. Meindl S, Rot A, Hoetzenecker W, Kato S, Cross HS, Elbe-Burger A. 2005. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells. Br J Dermatol 152:231-241.
26. Mizwicki MT, Bula CM, Bishop JE, Norman AW. 2005. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols. J Steroid Biochem Mol Biol 97:69-82.
27. Nakagawa T, Yuan J. 2000. Cross-talk between Two Cysteine Protease Families: Activation of Caspase-12 by Calpain in Apoptosis. J Cell Biol 150:887-894.
28. Narvaez CJ, Welsh J. 2001. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 276:9101-9107.
29. Nayeri S, Danielsson C, Kahlen JP, Schrader M, Mathiasen IS, Binderup L, Carlberg C. 1995. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene 11:1853-1858.
30. Nguyen M, d'Alesio A, Pascussi JM, Kumar R, Griffin MD, Dong X, Guillozo H, Rizk-Rabin M, Sinding C, Bougneres P, Jehan F, Garabedian M. 2006. Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): Dissociated responses of the CYP-24 and rel-B promoters to 1, 25-dihydroxyvitamin D3. J Bone Miner Res 21:886-894.
31. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A. 2005. Vitamin D and cancer: An update of in vitro and in vivo data. Front Biosci 10:2723-2749.
32. Quack M, Carlberg C. 2000. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J Mol Biol 296:743-756.
33. Rochel N, Moras D. 2006. Ligand binding domain of vitamin D receptors. Curr Top Med Chem 6:1229-1241.
34. Saramaki A, Banwell CM, Campbell MJ, Carlberg C. 2006. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34:543-554.
35. Schrader M, Kahlen J-P, Carlberg C. 1997. Functional characterization of a novel type of 1a, 25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. Biochem Biophys Res Commun 230:646-651.
36. Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J. 1997. Comparative effects of 1, 25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat 42:31-41.
37. Skowronski RJ, Peehl DM, Feldman D. 1995. Actions of vitamin D3, analogs on human prostate cancer cell lines: Comparison with 1, 25-dihydroxyvitamin D3. Endocrinology 136:20-26.
38. Thompson PD, Jurutka PW, Whitfield GK, Myskowski SM, Eichhorst KR, Dominguez CE, Haussler CA, Haussler MR. 2002. Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem Biophys Res Commun 299:730-738.
39. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E. 2001. Transcriptional control of intestinal cytochrome P-4503A by 1alpha, 25-dihydroxy vitamin D3. Mol Pharmacol 60:1399-1406.
40. Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ, Hewison M. 2005. Autocrine metabolism of vitamin D in normal and malignant breast tissue. T Clin Cancer Res 11:3579-3586.
41. Vaisanen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. 2005. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha, 25-Dihydroxyvitamin D3. J Mol Biol 350:65-77.
42. Valrance ME, Welsh J. 2004. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor. J Steroid Biochem Mol Biol 89-90:221-225.
43. Xie Z, Bikle DD. 1997. Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element. J Biol Chem 272:6573-6677.
44. Yee YK, Chintalacharuvu SR, Lu J, Nagpal S. 2005. Vitamin D receptor modulators for inflammation and cancer. Mini Rev Med Chem 5:761-768.
45. Zanello LP, Norman AW. 2004. Rapid modulation of osteoblast ion channel responses by 1alpha, 25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci U S A 101:1589-1594.
46. Zinser G, Welsh J. 2004. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Mol Endocrinol 18:2208-2223.
47. Zinser GM, McEleney K, Welsh J. 2003. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Mol Cell Endocrinol 200:67-80.
48. Zinser GM, Suckow M, Welsh J. 2005. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. J Steroid Biochem Mol Biol 97:153-164.